Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
18.27%
operating margin TTM
24.0%
revenue TTM
577.23 Million
revenue per share TTM
9.98$
valuation ratios | |
|---|---|
| pe ratio | 10.11 |
| peg ratio | -0.68 |
| price to book ratio | 1.84 |
| price to sales ratio | 1.85 |
| enterprise value multiple | 8.45 |
| price fair value | 1.84 |
profitability ratios | |
|---|---|
| gross profit margin | 77.16% |
| operating profit margin | 24.0% |
| pretax profit margin | 24.76% |
| net profit margin | 18.27% |
| return on assets | 12.48% |
| return on equity | 19.84% |
| return on capital employed | 20.45% |
liquidity ratios | |
|---|---|
| current ratio | 3.60 |
| quick ratio | 3.58 |
| cash ratio | 2.98 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 9.86 |
| operating cycle | 50.54 |
| days of payables outstanding | 32.56 |
| cash conversion cycle | 17.98 |
| receivables turnover | 8.97 |
| payables turnover | 11.21 |
| inventory turnover | 37.02 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.19 |
| debt equity ratio | 0.28 |
| long term debt to capitalization | 0.15 |
| total debt to capitalization | 0.22 |
| interest coverage | 14.23 |
| cash flow to debt ratio | 1.45 |
cash flow ratios | |
|---|---|
| free cash flow per share | 6.04 |
| cash per share | 13.45 |
| operating cash flow per share | 6.04 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 1.45 |
| short term coverage ratios | 4.01 |
| capital expenditure coverage ratio | 1,123.22 |
Frequently Asked Questions
When was the last time Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) reported earnings?
Harmony Biosciences Holdings, Inc. (HRMY) published its most recent earnings results on 04-11-2025.
What is Harmony Biosciences Holdings, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)'s trailing twelve months ROE is 19.84%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Harmony Biosciences Holdings, Inc. (HRMY) currently has a ROA of 12.48%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did HRMY's net profit margin stand at?
HRMY reported a profit margin of 18.27% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is HRMY's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.60 in the most recent quarter. The quick ratio stood at 3.58, with a Debt/Eq ratio of 0.28.